🇺🇸 Telmisartan 40mg in United States

13 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Dispensing Error — 2 reports (15.38%)
  2. Product Packaging Confusion — 2 reports (15.38%)
  3. Product Substitution Issue — 2 reports (15.38%)
  4. Abdominal Discomfort — 1 report (7.69%)
  5. Asthenia — 1 report (7.69%)
  6. Back Pain — 1 report (7.69%)
  7. Blood Pressure Increased — 1 report (7.69%)
  8. Covid-19 — 1 report (7.69%)
  9. Diarrhoea — 1 report (7.69%)
  10. Drug Ineffective — 1 report (7.69%)

Source database →

Telmisartan 40mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Telmisartan 40mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Telmisartan 40mg in United States?

University of Hawaii is the originator. The local marketing authorisation holder may differ — check the official source linked above.